Granisetron FDA Link Generic

A serotonin receptor (5HT-3 selective) antagonist that has been used as an antiemetic for cancer chemotherapy patients.

Also Known As:

Kytril; BRL-43694; BRL-43694A; Granisetron Hydrochloride; Granisetron Monohydrochloride; BRL 43694; BRL 43694A; BRL43694; BRL43694A; Hydrochloride, Granisetron; Monohydrochloride, Granisetron; 1- methyl- N- (endo- 9- methyl- 9- azabicyclo(3.3.1)non- 3- yl)- 1H- indazole- 3- carboxamide; 1H-Indazole-3-carboxamide, 1- methyl- N- (9- methyl- 9- azabicyclo(3.3.1)non- 3- yl; 1H-Indazole-3-carboxamide, 1- methyl- N- (9- methyl- 9- azabicyclo(3.3.1)non- 3- yl)- , endo-

Pharmalogical Action Categories:

Antiemetics

Organic Chemicals: 133
- Aza Compounds: 3
  - Azabicyclo Compounds
    - Granisetron: 895
Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Pyrazoles: 61
      - Indazoles: 179
        Granisetron: 895
- Bridged-Ring Heterocyclic Compounds
  - Heterocyclic Bridged Bicyclo Compounds
    - Azabicyclo Compounds
      - Granisetron: 895
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Indazoles: 179
      - Granisetron: 895

7-hydroxygranisetron

Bio-Agent Context: Research Results